Intestinal Failure
34
4
6
18
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
1 terminated out of 34 trials
94.7%
+8.1% vs benchmark
6%
2 trials in Phase 3/4
6%
1 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 18 completed trials
Clinical Trials (34)
Spectral Lighting and Metabolism
Effects of Oral Citrulline on Protein Metabolism in Patients With Intestinal Failure (Citrugrêle 2)
Effects of Whey Protein and Resistance Training on Muscle Mass in Patients With Intestinal Failure
Resting Energy Expenditure by Gastrointestinal Functional Status
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
Weaning is Winning? (WeWin Study)
8.4% Sodium Bicarbonate Locks in Intestinal Failure
Video Training Supplementation for Patients Discharged on Home Parental Nutrition
CGM-Assisted Management of PN
The LIFT-ECHO Last Mile Project
Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients
AI-driven Total Parenteral Nutrition Platform
Chyme Reinfusion for Type 2 Intestinal Failure
Optimised Osmolality in Oral Supplements Optimised Osmolality in Oral Supplements
Effect of Parenteral Support on FibroScan in Short Bowel Syndrome
Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure
Risk Factors for Catheter-Related Bloodstream Infections in Hospitalized Intestinal Failure Patients
Effect of Vitamin D on Skeletal Muscle Function and Qol in Patients With Chronic Intestinal Failure/Insufficiency
Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)
Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments